HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Clinical trial NCT05952947 · RECRUITING

Trial details

NCT number: NCT05952947
Sponsor: HRYZ Biotech Co.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Head and Neck Squamous Cell Carcinoma Carcinoma of Vagina Carcinoma of Penis Anal Cancer Carcinoma of Vulva

Start date: 2023-11-01
Primary completion: 2027-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.